AI Pharma Innovation: Drug Discovery Summit 2018

AI Pharma Innovation: Drug Discovery Summit is organized by Hanson Wade and will be held during Feb 26 - 28, 2018 at Le Meridien San Francisco, San Francisco, California, United States of America.

The AI Pharma Innovation: Drug Discovery Summit will bring together the leading scientists, technology developers, and key decision makers in the pharmaceutical and biotechnology industries.

Assess and address key challenges standing in the way of the adoption and practical application of AI and machine learning technologies across the early phases of drug discovery value chain in order to increase levels of pharmaceutical innovation and maximize drug discovery assets.

This meeting seeks to provide new insights and experiences on how to move away from the hype surrounding AI and machine learning technologies and move towards practical application of AI based innovations to optimize resources for maximum research and discovery, especially within the hit-to-lead phase of drug discovery.

Prices:
Conference 2 Workshops Earlybird (Book by 24/11/17): USD 3097,
Conference 2 Workshops (standard rate): USD 3797,
Conference 1 Workshop Earlybird (Book by 24/11/17): USD 2598,
Conference 1 Workshop (standard rate): USD 3298,
Conference Earlybird (Book by 24/11/17): USD 2099,
Conference (Standard rate): USD 2799,
Individual Workshop: USD 599,
2 workshops: USD 998.

Speakers: Brandon Allgood (Numerate), Ed Addison (Cloud Pharmaceuticals), Michael Palovich (GSK), Francis Kendall (Roche), Hugo Ceulemans (Johnson and Johnson), Natalija Jovanovic (Sanofi).

Additional details will be posted as soon as they are available.